VinBrain Joint Stock Company

Number 7 Bang Lang 1 Street; Vinhomes Riverside Ecological Urban Area, Long Bien District; Hanoi; Vietnam  All Vietnam companies → Founded 2019
Clinical AI Platform Imaging AI Specialist
Emergency Medicine Gastroenterology Oncology Pulmonology
Gastroenterology AI Oncology AI Radiology & Imaging AI
Acquired — Undisclosed (Vingroup invested over $126 million prior to acquisition)

Products

DrAid™ for Liver Segmentation
VinBrain Joint Stock Company
Gastroenterology AI
DrAid™ for Liver Segmentation is an FDA-cleared, web-based AI software by VinBrain that assists healthcare professionals in analyzing liver images from CT scans, providing semi-automated liver segmentation and tools for manual refinement and lesion identification to aid in evaluation and treatment planning.
DrAid for Radiology v1
VinBrain Joint Stock Company
Radiology & Imaging AI
DrAid for Radiology v1 is an FDA-cleared AI assistant by VinBrain, designed to enhance diagnostic imaging for radiologists. It uses AI to interpret chest X-rays, identify abnormalities like pneumothorax, and prioritize cases, improving accuracy and workflow efficiency.

See all 2 products →

About VinBrain Joint Stock Company

VinBrain Joint Stock Company is a pioneering healthcare AI company that develops advanced AI-based solutions to enhance medical diagnostics, treatment, prediction, and prevention, as well as improve operational efficiency within healthcare systems. The company’s platform leverages computer vision, generative AI, and deep learning to streamline workflows for medical professionals, particularly radiologists. Its core offerings include tools that identify and differentiate cancerous cells and tissues, analyze patient medical histories for risk factors, and automatically generate comprehensive reports from healthcare data.

Key products developed by VinBrain include DrAid™, an AI-powered doctor assistant for automated chest X-ray diagnosis and screening, which has been deployed in over 100 hospitals across Vietnam and the USA. Additionally, VinBrain developed AIviCare, a telehealth solution that provided critical support to thousands of COVID-19 patients in Vietnam. The company’s AI models are trained on extensive datasets, with DrAid™ alone having processed over 5.4 million medical image scans. VinBrain’s innovative AI tools are integrated into more than 182 hospitals across various countries, including Vietnam, the United States, India, and Australia, aiming to improve patient outcomes and enhance the quality and consistency of healthcare globally.

Focus Areas

AI in medical diagnostics medical imaging (X-ray CT MRI) treatment planning prediction prevention hospital operational efficiency telehealth intelligent video analytics automatic speech recognition natural language processing text-to-speech cancer detection (liver rectal) tuberculosis screening

Business Intelligence

Key InvestorsVingroup (former primary investor), MedTech Innovator (accelerator/incubator), NVIDIA (acquirer)
PartnershipsNVIDIA (before acquisition, as Inception Premier Member and tech platform user), Microsoft (Azure cloud, data sharing, R&D), Stanford University (data use agreement, RadGraph method, research collaboration), Ferrum Health, VIKOMED
AcquisitionsAcquired by NVIDIA Corporation in December 2024
TechnologyNVIDIA DGX A100 supercomputer, NVIDIA DGX SuperPOD, NVIDIA Clara healthcare application framework, MONAI open-source framework, NVIDIA NeMo conversational AI toolkit, NVIDIA AI Enterprise, Microsoft Azure cloud
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Medical Diagnostics & Imaging
VinBrain specializes in AI-powered medical diagnostics across various modalities, including X-ray, CT, and MRI. Their solutions are designed to enhance the accuracy and speed of disease detection, with a specific focus on critical areas like liver and rectal cancer detection, as well as tuberculosis screening.
Treatment Planning & Prediction
The company offers AI tools that assist in treatment planning, disease prediction, and prevention strategies. This aims to provide physicians with data-driven insights to optimize patient care pathways and outcomes.
Hospital Operational Efficiency
VinBrain develops AI solutions to improve the overall operational efficiency of hospitals. This can include optimizing workflows, resource allocation, and reducing administrative burdens, allowing healthcare providers to focus more on patient care.
Telehealth & Remote Care
They are involved in telehealth solutions, leveraging AI to support remote consultations, monitoring, and care delivery, thereby expanding access to healthcare services.
Advanced AI & Data Processing
Their expertise extends to intelligent video analytics, automatic speech recognition, natural language processing (NLP), and text-to-speech technologies. These capabilities can be applied to various aspects of healthcare, from patient monitoring to clinical documentation.
Key Differentiators
VinBrain stands out with its comprehensive suite of AI solutions covering a broad spectrum of healthcare needs, from precise diagnostic assistance in critical diseases (cancer, TB) to operational enhancements and advanced communication tools. Their integration of multiple AI modalities (computer vision, NLP, speech) offers a holistic approach to healthcare challenges.
Technology Stack (Inferred)
Leveraging deep learning frameworks (e.g., TensorFlow, PyTorch), cloud computing for scalability, big data analytics, and specialized algorithms for computer vision, natural language processing, and speech recognition to power their AI models.
Physician Tip

For physicians, VinBrain's solutions offer significant advantages by enhancing diagnostic accuracy and speed, particularly in complex cases like cancer and TB. The AI-driven insights can streamline treatment planning and potentially lead to earlier disease detection and intervention. Operational efficiency tools can reduce administrative overhead, freeing up valuable time for patient interaction. Furthermore, their telehealth and advanced communication technologies (speech recognition, NLP) can improve patient engagement, facilitate remote care, and optimize clinical documentation, ultimately contributing to better patient outcomes and reduced physician burnout.

VinBrain's AI solutions are designed for seamless integration into existing healthcare IT infrastructure, including Picture Archiving and Communication Systems (PACS), Electronic Medical Records (EMR) / Electronic Health Records (EHR) systems, and Hospital Information Systems (HIS), to ensure a cohesive and efficient workflow within clinical environments.

Products by VinBrain Joint Stock Company

2 products in the directory

DrAid™ for Liver Segmentation
VinBrain Joint Stock Company
Gastroenterology AI
DrAid™ for Liver Segmentation is an FDA-cleared, web-based AI software by VinBrain that assists healthcare professionals in analyzing liver images from CT scans, providing semi-automated liver segmentation and tools for manual refinement and lesion identification to aid in evaluation and treatment planning.
DrAid for Radiology v1
VinBrain Joint Stock Company
Radiology & Imaging AI
DrAid for Radiology v1 is an FDA-cleared AI assistant by VinBrain, designed to enhance diagnostic imaging for radiologists. It uses AI to interpret chest X-rays, identify abnormalities like pneumothorax, and prioritize cases, improving accuracy and workflow efficiency.

What the Web Says

VinBrain Joint Stock Company is a Vietnamese healthcare AI startup, funded by Vingroup and recently acquired by NVIDIA. They specialize in AI-powered medical solutions, with their flagship product, DrAid, assisting in the detection of abnormalities in X-rays and CT scans. VinBrain's products are deployed in over 180 hospitals across Vietnam, the US, India, Australia, and New Zealand. The company is recognized for its innovative technology and collaborations with major tech companies and academic institutions.

Overall: Positive

Strengths

  • AI-powered medical solutions enhance diagnostic accuracy and efficiency.
  • DrAid is FDA-cleared for detecting collapsed lungs from chest X-rays.
  • Strong collaborations with Microsoft, NVIDIA, and top universities like Stanford and Harvard.
  • Focus on diverse data sets to reduce bias in AI models.
  • Offers an attractive remuneration package and benefits for employees, including health insurance and professional training.
  • High-performing, agile startup culture with talented colleagues.

Limitations

  • Limited public product reviews on major platforms like G2, Glassdoor, and Capterra.
  • Reddit discussions suggest the acquisition value by NVIDIA might not be as high as some assume, and revenue figures are not widely disclosed.
  • Some Reddit users express general skepticism or negative opinions about Vingroup, VinBrain's former parent company, regarding business practices and investment.
  • Potential for challenges in tailoring AI apps to highly specific equipment and operating procedures, as noted in a review for a similar product.
  • Lack of detailed employee reviews on Glassdoor, G2, and Capterra specifically for VinBrain.

Based on reviews from: HealthTechAsia, ITviec, NVIDIA, News Hub Asia, Reddit, MedTech World

Last updated: 2026-07-19

Videos

News, demos, and interviews about VinBrain Joint Stock Company.

Loading videos...

Videos load interactively. If none appear, search YouTube for VinBrain Joint Stock Company →

View all on YouTube

Press & Coverage

Vietnam News
NVIDIA acquires Vingroup's AI healthcare solution company
NVIDIA has acquired VinBrain, a Vietnamese AI healthcare startup, following an agreement with the Vietnamese government to establish AI research and data centers in Vietnam. VinBrain, an affiliate of Vingroup, has provided AI-based equipment and tools to 182 hospitals globally.
2024-12
MarketScreener
NVIDIA Corporation acquired VinBrain LLC from Vingroup Joint Stock Company and others.
NVIDIA Corporation completed the acquisition of VinBrain LLC from Vingroup Joint Stock Company and other stakeholders on December 5, 2024. The financial details of the acquisition were not disclosed.
2024-12
Media OutReach Newswire
VinBrain offers comprehensive AI and data platforms, including an annotation service aiding 8,000 disadvantaged students
VinBrain announced record corporate momentum with over 5.4 million medical image scans on its DrAidu2122 platform and a commitment to aid 8,000 disadvantaged students through an annotation service. The company has deployed its AI solutions in over 182 hospitals globally.
2024-07
VietNamNet
Nvidia's Vietnam expansion: New AI hubs, VinBrain acquisition, and more
Nvidia announced the acquisition of VinBrain, a Vietnamese AI startup specializing in medical solutions, alongside plans to establish AI R&D and data centers in Vietnam. VinBrain's DrAid, an AI-powered diagnostic tool, is already in use in major hospitals.
2024-12
Theinvestor.vn
Nvidia acquires AI unit of Vietnamese private giant Vingroup
Nvidia has acquired VinBrain, an AI developer under Vietnamese conglomerate Vingroup, with Nvidia CEO Jensen Huang confirming the acquisition and plans to turn VinBrain into a major design center in Vietnam. VinBrain's website has been updated to reflect its integration into Nvidia.
2024-12
Vietnam Investment Review (VIR)
VinBrain inks deal to transfer AI technology for tuberculosis screening
VinBrain signed a commercial agreement with Global Fund to transfer its DrAidu2122 AI technology for Tuberculosis (TB) screening and detection as part of Vietnam's National Tuberculosis Prevention Campaign. This initiative aims to screen 1 million potential TB cases starting in April 2024.
2024-02
HealthTechAsia
NVIDIA acquires healthcare AI startup VinBrain
NVIDIA has acquired Hanoi-based startup VinBrain, which specializes in AI-powered medical solutions and has provided equipment to 182 hospitals globally. VinBrain's DrAidu2122 CT Liver Cancer solution received the Gold Award at the ASEAN Digital Awards in 2024.
2024-12
NVIDIA Blog
Vietnam's VinBrain Deploys Healthcare AI Models to 100+ Hospitals
VinBrain has deployed its DrAid AI software, which analyzes medical images for over 120,000 patients monthly, in more than 100 hospitals across Vietnam, Myanmar, New Zealand, and the U.S. DrAid is FDA-cleared for detecting collapsed lungs from chest X-rays.
2023-02

Frequently Asked Questions

VinBrain's flagship product, DrAid, provides AI-powered automated chest X-ray diagnosis and screening for 21 abnormalities related to the heart, lungs, and bones, and is FDA-cleared for detecting features suggestive of collapsed lungs. They also offer specialized AI models like DrAid Diagnosis for chest X-rays, DrAid Treatment for MRI registration and segmentation, and VinDr-BrainCT and VinDr-BrainMR for diagnosing brain lesions on CT and MRI images. Overall, VinBrain has developed over 300 AI models to process various medical imaging data.
VinBrain has developed innovative AI-powered solutions for cancer detection and treatment aiding, including CT Liver Cancer D&T and MRI Rectal Cancer D&T. These solutions are designed for early detection, classification, localization, and measurement of cancer, with CT Liver Cancer D&T notably capable of detecting hepatocellular carcinoma (HCC). The Oncology D&T platform aims to assist oncologists in making more accurate diagnoses and informed treatment decisions.
VinBrain offers DrAidu2122 for TB Screening, an AI-powered solution that accurately analyzes chest X-ray images to detect TB-related abnormalities with high sensitivity and specificity (up to 96%). This technology significantly reduces diagnosis time and screening costs, making large-scale screenings more accessible, especially in underserved regions. VinBrain has partnered with the Global Fund to transfer this technology for widespread use in national TB prevention campaigns.
VinBrain's AI solutions aim to improve hospital operational efficiency through products like DrAidu2122 Enterprise Data Solution, which centralizes, transforms, and intelligently manages medical data, and DrAidu2122 Copilot, a medical AI-powered virtual assistant for data lookup and productivity enhancement. For treatment planning, their DrAid Treatment module focuses on MRI registration and segmentation, and they are developing an AI-based system for prognosis recommendations.
VinBrain integrates advanced AI capabilities including natural language processing (NLP), automatic speech recognition (ASR), and text-to-speech (TTS) into its platforms. DrAid Smart Assistant, for example, utilizes ASR and TTS for voice commands and medical report editing. Additionally, VinBrain is developing a telehealth product designed to analyze lab test results, medical reports, and other electronic health records.
VinBrain's DrAid product is the first AI software for X-ray diagnostics in Southeast Asia to receive FDA approval, specifically for detecting features suggestive of collapsed lungs, and adheres to HIPAA and NIST standards by employing Azure for data security. The company is funded by Vingroup, Vietnam's largest conglomerate, ensuring strong financial backing and stability. VinBrain also collaborates with key partners like NVIDIA, Microsoft, Stanford University, Harvard University, and the Global Fund for R&D, product validation, and global deployment.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]

Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]

Columbia University, through its online learning platform edX, offers a range of educational programs, including those focused on artificial intelligence and its applications in healthcare. While not a direct AI product company, Columbia University provides foundational and advanced courses that equip physicians and healthcare providers with the knowledge and skills to understand, evaluate, and potentially […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.